Study With Two Coenzyme Q10 Products

Comparative Single-dose Bioavailability Clinical Study of Two Different Coenzyme Q10 Products

The randomized, open-label, two period crossover single-dose bioavailability study with two coenzyme Q10 products

The randomized, open-label, two period crossover single-dose bioavailability study with two coenzyme Q10 products will include 35 subjects who will test two different coenzyme Q10 products. Plasma concentration of coenzyme Q10 will be measured.

Inclusion Criteria:

• subject informed consent form
• aged between 50 and 65 years old
• body mass for women 70± 5 kg and for men 85± 5 kg
• non-smoking
• healthy, without cardio-vascular diseases, diabetes, neurodegenerative diseases
• absence of any prescribed medication during the study
• willing to avoid a consumption of any food supplements at least 2 weeks before and during the study

Exclusion Criteria:

• cardio-vascular diseases, diabetes, neurodegenerative diseases, gastrointestinal disorders, pregnancy, breast-feeding
• intake of any food supplements within two week of the beginning of the study
• drug or alcohol abuse